Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7272
-0.0225 (-3.00%)
Feb 25, 2026, 11:44 AM EST - Market open
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $16.27 million as of February 25, 2026. Its market cap has decreased by -21.01% in one year.
Market Cap
16.27M
Enterprise Value
10.88M
1-Year Change
-21.01%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $16.27M, a decrease of -47.00%. That is a compound annual growth rate of -7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 16.80M | 4.35% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 17.47M |
| FibroBiologics | 16.50M |
| Hoth Therapeutics | 16.29M |
| Lexaria Bioscience | 16.21M |
| Cadrenal Therapeutics | 16.00M |
| CASI Pharmaceuticals | 15.72M |
| Curis | 15.20M |
| IN8bio | 15.14M |